Protocol Name: A Phase 3, Randomized, Double-Blind,Placebo-Controlled Study of Povetacicept in Adults with IgA Nephropathy (Rainier)
Sponsor: Alpine Immune Sciences / Vertex
Indication: IgA Nephropathy
GFR: ≥30
Making a difference with your help.